CytRx preclinical data

In a mouse xenograft model of ovarian cancer, 24 mg/kg INNO-206 led to significantly greater reductions in tumor size compared to 8 mg/kg doxorubicin. Additionally, mice treated with 12 mg/kg INNO-206...